Results 31 to 40 of about 1,326 (158)
Frontiers in Neurology, 2016 Neuromyelitis optica spectrum disorder (NMOSD) is a diverse condition which not only encompasses isolated longitudinally extensive transverse myelitis and optic neuritis but also includes area postrema syndrome, acute brainstem syndrome, symptomatic ...
UJJAWAL eROY +5 more
doaj +1 more source
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
Frontiers in Neurology, 2020 Tumefactive multiple sclerosis (MS) is a rare variant of MS that may lead to a rapidly progressive clinical deterioration requiring a multidisciplinary diagnostic workup.
Katharina Breitkopf +15 more
doaj +1 more source
A case of recurrent tumefactive demyelination or tumefactive multiple sclerosis
Sri Lanka Journal of Child Health, 2021 No abstract availableSri Lanka Journal of Child Health, 2021: 50(2): 342 ...
Sachin Damke +2 more
openaire +2 more sources
Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2019 Objective Large demyelinating lesions with possible mass effect (tumefactive multiple sclerosis or tumefactive demyelination) can be mistaken for tumour-like space-occupying lesions suggesting a malignant outcome.
Staley A Brod +2 more
doaj +1 more source
Frontiers in Immunology, 2023 Current understanding of Multiple Sclerosis (MS) pathophysiology implicates perturbations in adaptive cellular immune responses, predominantly T cells, in Relapsing-Remitting forms (RRMS).
Aigli G. Vakrakou +13 more
doaj +1 more source
Tumefactive multiple sclerosis: an uncommon diagnostic challenge [PDF]
Journal of Chiropractic Medicine, 2011 This case report describes a rare presentation of multiple sclerosis (MS) that was initially diagnosed as a peripheral nerve lesion in the emergency department.A 30-year-old woman presented to a chiropractic teaching clinic with a complaint of a sudden right foot drop.
Martha A, Kaeser +4 more
openaire +2 more sources
Frontiers in Immunology, 2022 ObjectiveTo track the clinical outcomes in patients who initially presented with tumefactive demyelinating lesions (TDLs), we summarized the clinical characteristics of various etiologies, and identified possible relapse risk factors for TDLs ...
Xinnan Li +9 more
doaj +1 more source
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
Case Reports in Radiology, 2012 Tumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement.
Hossein Kalanie +3 more
doaj +1 more source
A Case of Tumefactive Multiple Sclerosis
Japanese Journal of Neurosurgery, 2012 Background: Tumefactive multiple sclerosis (tMS) is a demyelinating disease which presents imaging features mimicking a malignant brain tumor, thereby requiring brain biopsy in most cases for definitive diagnosis. Case presentation: A 37-year-old man visited our clinic complaining of mild motor weakness in his left leg (5-/5).
Shoko M. Yamada +7 more
openaire +3 more sources
Tumefactive multiple sclerosis lesions under fingolimod treatment [PDF]
Neurology, 2012 Fingolimod is an oral sphingosine 1-phosphate receptor modulator that prevents recirculation of lymphocyte subsets from lymph nodes. It decreases the number of relapses, slows the progression of disability, and improves MRI endpoints in patients with relapsing-remitting multiple sclerosis (RRMS).1 Infrequent but specific side effects are bradycardia ...
Visser, F. +4 more
openaire +4 more sources